No needle, no proof: the smart rings that claim to read your blood sugar.

The pitch, now sized for your finger

Smart rings are the fastest-growing wearable on the market. IDC figures reported in January put their 2026 shipment growth near 49 percent, while smartwatches crawl along in the low single digits, and that momentum comes off a small base of only a few million rings a year. Into that boom, two devices are making a promise that used to require a needle.

The Circular Ring 2 sells for about $239 with no subscription. Its makers say a blood pressure feature came first, with non-invasive blood glucose trend tracking promised for late 2026. The PIN Pulse, funded on Kickstarter at $249 and heading toward a $499 retail price, goes further on paper: blood pressure, a "blood glucose risk assessment," sleep apnea signs, and more than a dozen other metrics, all with no monthly fee. Both readings are taken on demand through the app, behind a few guided pre-checks.

Notice how carefully both companies use one word: trends. Circular says its glucose feature "won't replace medical-grade glucose monitoring, especially for people with diabetes." That caveat is the whole story, and most buyers will scroll right past it.

How a ring claims to read your blood sugar

A finger prick and a continuous glucose monitor both touch fluid that carries glucose. A ring touches nothing but skin. Instead, it shines light into your finger and watches how that light bounces back, a technique called photoplethysmography, or PPG. Software then infers a glucose trend from tiny shifts in the reflected signal. Blood pressure runs on a related trick: the ring times how long each pulse takes to travel, a measure called pulse transit time, and estimates pressure from that timing.

This is inference, not chemistry. The device never touches a glucose molecule. It reads an optical shadow, then leans on machine learning to smooth the guess into a friendly line on a chart. The trouble is that skin tone, hydration, temperature and how snugly the ring sits all bend that same signal, which is exactly why light-based glucose has defeated far bigger companies.

What the evidence actually shows

Here is the uncomfortable part. Non-invasive glucose is the field's long-sought holy grail, and no consumer device has been proven to reach it. No product has cleared that bar since the GlucoWatch vanished from the market more than fifteen years ago. In a February 2024 safety communication, the U.S. Food and Drug Administration was blunt: it "has not authorized, cleared, or approved any smartwatch or smart ring that is intended to measure or estimate blood glucose values on its own." The agency warned that a false reading acted on with insulin could bring "mental confusion, coma, or death within hours of the error."

Endocrinologists who study the technology are no softer. The optics are genuinely hard, and the fluids a ring can reach do not track blood sugar cleanly. If you want a device that measures interstitial glucose minute by minute, that is a continuous glucose monitor, and our guide to CGMs for people without diabetes explains what those sensors do and where even they fall short. A real CGM parks a tiny filament under the skin and samples the fluid around your cells; a ring stays on the surface and never breaks it. A ring is not that, and it does not claim under oath to be.

The rule change that let the marketing sprint ahead

The timing is not an accident. On 6 January 2026, the FDA updated its General Wellness guidance so a product that uses non-invasive sensing to estimate parameters such as blood glucose, blood pressure or oxygen can be treated as a low-risk general wellness product, outside medical-device review, as long as its claims stay wellness-only and steer clear of disease.

Read that carefully, because the catch is real. A company can now ship a glucose-estimating ring without a single 510(k) clearance, provided it never says the ring diagnoses or manages anything. The guidance still bars a device from showing numbers that "mimic those used clinically" when they are not validated, and it treats even a minimally invasive microneedle as too risky for the wellness bin. The practical effect is a fast lane where marketing can promise a metric long before anyone proves the ring delivers it.

How to think about buying one

Buy the ring for what it does, not for what the headline implies. As a sleep, heart-rate and activity tracker, a good ring is genuinely useful, and a gentle push to notice your own patterns has value. Treat any glucose or blood pressure figure as a rough trend line, not a number you would dose a medication against.

If you have diabetes or pre-diabetes, this matters more, not less. Keep your cleared meter or CGM, and talk to your clinician before you trust any finger or wrist gadget with a decision. The tell sits in the fine print: when a product labels its own output "wellness," that is the maker quietly admitting it is not medicine.

Our take

The rings are real, the sensors are clever, and the sleep and heart data are worth having. The glucose promise is not there yet: no ring has been shown to measure blood sugar without breaking the skin, and the FDA has cleared exactly none for the task. Enjoy the trends, skip the miracle, and keep a proven device for anything that truly counts.